Diligence memo · auto-generated · as of July 2, 2026
Accolade, Inc.
Accolade, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Accolade, Inc. operates in Other Health Care, based in PLYMOUTH MEETING. Contact Accolade today to see what Personalized Healthcare is all about.
Capital & rounds (filed)filed
Accolade, Inc. has raised $661M in disclosed capital across 11 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $325M on 2021-06-09.
Most recent recorded round closed around 2021-09-30.
Valuation (modeled)modeled
Provath models Accolade, Inc. at approximately $200M (range $60M–$380M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.06× the median modeled value of Series D+ Other Health Care companies in 2019–2021 (26 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 13 months.
Last raise 4.8 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 28.9× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 100% of Other Health Care peers (5377 compared).
Modeled value ranks above 87% of those peers.
Closest niche peers: ZAHN Parent, LLC, Covetrus, Inc., EQH Parent, LLC, SonerMed, LLC, Fs Usme Lp.
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.